Search results
Why are drug names so long and complicated? A pharmacist explains the logic behind the nomenclature
The Conversation via Yahoo News· 1 year agoHaving multiple prescriptions is difficult enough to keep track of, let alone ones with complicated...
Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Dr. Reddy's Laboratories and Teva...
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 14, 2023 – Today, Zacks Equity Research discusses...
'Everybody is on it': A 'game-changing' weight-loss drug is NYC's hottest new trend
INSIDER via Yahoo News· 1 year agoMarianne Ayala/Insider Semaglutide, the weight-loss drug sold as Ozempic and Wegovy, is a hot ticket...
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoSchrödinger, Inc. (NASDAQ:SDGR) Q1 2023 Earnings Call Transcript May 4, 2023 Operator: Thank you for...
After eye drop recall, should consumers be worried about buying over-the-counter drugs?
USA TODAY via Yahoo News· 6 months agoWhen Judith Gregory’s left eye became red, teary and painful last year, she made the first of many...
Aquestive (AQST) to Report Q2 Earnings: What's in Store?
Zacks via Yahoo Finance· 10 months agoAquestive AQST is scheduled to report second-quarter 2023 results on Aug 7, after market close. The...
The One Generative AI Risk That No One Is Talking About
Investor's Business Daily· 9 months agoThe struggle over who controls the course of key technology, and how much, is as old as the tech...
DaVita Inc. (NYSE:DVA) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoDaVita Inc. (NYSE:DVA) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good evening. My...
Q4 2023 Schrodinger Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Matthew Luchini; Director of Investor Relations & Corporate Affairs; Schrodinger Inc Ramy Farid; President, Chief Executive Officer, & Board Member; Schrodinger Inc Geoff Porges ...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 weeks agoImage source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL) Q1 2024 Earnings Call May 07,...